BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Elrashidy H, Elbahrawy A, El-Didamony G, Mostafa M, George NM, Elwassief A, Saeid Mohamed AG, Elmestikawy A, Morsy MH, Hashim A, Abdelbasseer MA. Antibody levels against hepatitis B virus after hepatitis B vaccination in Egyptian diabetic children and adolescents. Hum Vaccin Immunother 2013;9:2002-6. [PMID: 23787761 DOI: 10.4161/hv.25426] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Elbahrawy A, Ibrahim MK, Eliwa A, Alboraie M, Madian A, Aly HH. Current situation of viral hepatitis in Egypt. Microbiol Immunol 2021;65:352-72. [PMID: 33990999 DOI: 10.1111/1348-0421.12916] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
2 Chen Y, Lv H, Gu H, Cui F, Wang F, Yao J, Xia S, Liang X. The effects of different dosage levels of hepatitis B vaccine as booster on anti-HBs-negative children 5-15 y after primary immunization; China, 2009-2010. Hum Vaccin Immunother 2014;10:498-504. [PMID: 24192508 DOI: 10.4161/hv.26936] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
3 Zimmermann P, Curtis N. Factors That Influence the Immune Response to Vaccination. Clin Microbiol Rev. 2019;32. [PMID: 30867162 DOI: 10.1128/cmr.00084-18] [Cited by in Crossref: 132] [Cited by in F6Publishing: 74] [Article Influence: 44.0] [Reference Citation Analysis]
4 Elrashidy H, El-Didamony G, Elbahrawy A, Hashim A, Alashker A, Morsy MH, Elwassief A, Elmestikawy A, Abdallah AM, Mohammad AG, Mostafa M, George NM, Abdelhafeez H. Absence of occult hepatitis B virus infection in sera of diabetic children and adolescents following hepatitis B vaccination. Hum Vaccin Immunother 2014;10:2336-41. [PMID: 25424940 DOI: 10.4161/hv.29521] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
5 Esposito S, Mariotti Zani E, Torelli L, Scavone S, Petraroli M, Patianna V, Predieri B, Iughetti L, Principi N. Childhood Vaccinations and Type 1 Diabetes. Front Immunol 2021;12:667889. [PMID: 34512622 DOI: 10.3389/fimmu.2021.667889] [Reference Citation Analysis]
6 Rezaee-Zavareh MS, Einollahi B. Hepatitis B vaccination: needs a revision. Hepat Mon 2014;14:e17461. [PMID: 24734095 DOI: 10.5812/hepatmon.17461] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
7 Verstraeten T, Fletcher MA, Suaya JA, Jackson S, Hall-Murray CK, Scott DA, Schmöle-Thoma B, Isturiz RE, Gessner BD. Diabetes mellitus as a vaccine-effect modifier: a review. Expert Rev Vaccines 2020;19:445-53. [PMID: 32516066 DOI: 10.1080/14760584.2020.1760098] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
8 Salehi-Vaziri M, Sadeghi F, Almasi Hashiani A, Gholami Fesharaki M, Alavian SM. Hepatitis B Virus Infection in the General Population of Iran: An Updated Systematic Review and Meta-Analysis. Hepat Mon 2016;16:e35577. [PMID: 27257428 DOI: 10.5812/hepatmon.35577] [Cited by in Crossref: 40] [Cited by in F6Publishing: 26] [Article Influence: 6.7] [Reference Citation Analysis]
9 Onal Z, Ersen A, Bayramoglu E, Yaroglu Kazancı S, Onal H, Adal E. Seroprotection status of hepatitis B and measles vaccines in children with type 1 diabetes mellitus. J Pediatr Endocrinol Metab 2016;29:1013-7. [PMID: 27658137 DOI: 10.1515/jpem-2015-0211] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]